Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Wockhardt Limited
WOCKPHARMACurrent price
1 388.15 INR
-47 INR (-3.26%)
Last closed
1 443.05 INR
Company
www.wockhardt.com
ISIN
INE049B01025
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
248 314 025 248 INR
Yield for 12 month
+197.79 %
1Y
3Y
5Y
10Y
15Y
WOCKPHARMA
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company provides contract manufacturing services. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India. Address: Wockhardt Towers, Mumbai, India, 400051
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
38 787.95 INRP/E ratio
–Dividend Yield
–Current Year
+28 057 973 929 INR
Last Year
+26 669 662 572 INR
Current Quarter
+8 138 723 868 INR
Last Quarter
+7 434 507 974 INR
Current Year
+7 766 495 446 INR
Last Year
+15 492 750 028 INR
Current Quarter
+5 150 836 359 INR
Last Quarter
+2 132 768 202 INR
Key Figures WOCKPHARMA
1 year
3 years
5 years
10 years
EBITDA
2 090 012 241 INR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.17 %
PEG Ratio
–
Return On Equity TTM
-12.89 %
Wall Street Target Price
38 787.95 INR
Revenue TTM
29 426 165 733 INR
Book Value
215.96 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.80 %
Dividend Yield
–
Gross Profit TTM
14 879 076 166 INR
Earnings per share
-19.87 INR
Diluted Eps TTM
-19.87 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
840.60 %
Profit Margin
-11.73 %
Dividend Analytics WOCKPHARMA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History WOCKPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
17.11.2016
Forward Annual Dividend Yield
–
Last Split Factor
10:5
Payout Ratio
–
Last Split Date
28.04.2004
Dividend Date
–
Stock Valuation WOCKPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
9.10
Price Sales TTM
8.44
Enterprise Value EBITDA
120.53
Price Book MRQ
7.27
Financials WOCKPHARMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators WOCKPHARMA
For 52 weeks
405.08 INR
1 592.48 INR
50 Day MA
1 344.07 INR
Shares Short Prior Month
–
200 Day MA
931.84 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart